Endocannabinoids in the immune system and cancer
- 1 February 2002
- journal article
- review article
- Published by Elsevier in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 66 (2-3), 319-332
- https://doi.org/10.1054/plef.2001.0355
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Effects of CTx and 8-Bromo-cAMP on LPS-Induced Gene Expression of Cytokines in Murine Peritoneal MacrophagesBiochemical and Biophysical Research Communications, 2000
- Unsaturated Long-Chain N-Acyl-vanillyl-amides (N-AVAMs): Vanilloid Receptor Ligands That Inhibit Anandamide-Facilitated Transport and Bind to CB1 Cannabinoid ReceptorsBiochemical and Biophysical Research Communications, 1999
- Δ9‐Tetrahydrocannabinol induces apoptosis in C6 glioma cellsFEBS Letters, 1998
- Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with ApoptosisJournal of Biological Chemistry, 1998
- The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein couplingFEBS Letters, 1995
- Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signalsCell, 1995
- Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cellsLife Sciences, 1995
- The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamideFEBS Letters, 1995
- Cyclic AMP Is an Essential Factor in Immune ResponsesBiochemical and Biophysical Research Communications, 1995
- Inhibition of adenylate cyclase by Δ9-Tetrahydrocannabinol in mouse spleen cells: A potential mechanism for cannabinoid- mediated immunosuppressionLife Sciences, 1992